The European Union's drugs regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's small impact on ...

A group of European startups has called for rapid action to slash EU regulations after a landmark declaration from the D9+ ...

The University of Malaga has been selected for the first time ever to coordinate an innovation project under the Horizon ...

Schemes seek to attract top scientific talent from the US as Trump cuts research funding, attacks universities ...

On March 25th the EOSC Tripartite Governance joined in Krakow to define key developments for advancing research data and ...

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

The share buy-back program will start on March 26, 2025, and is expected to end no later than July 10, 2025 (unless Genmab terminates or suspends the program).

The global Skincare Supplement Market is experiencing significant expansion, driven by increasing consumer awareness ...

Nasscom, today, successfully hosted the first edition of the Global Confluence 2025 at Hotel Shangri-La, New Delhi. The event ...

Western officials have accused Russia and its proxies of staging dozens of attacks and other incidents across Europe since ...

Welcome to the Daily News Brief, CFR’s flagship morning newsletter summarizing the top global news and analysis of the ...

The Oldham-based football club - Avro FC - continue to jet set around Europe as they push the pace in the Fenix Trophy ...